Squamous Cell Carcinoma Antigen: Clinical Application and Research Status

Area of Science:

• Oncology
• Immunology
• Biochemistry

Background:

• Squamous cell carcinoma antigen (SCCA) and its complexes with IgM are implicated in physiological and pathological processes.
• SCCA is recognized as a potential tumor marker for squamous cancers and treatment monitoring.
• Existing clinical studies on SCCA's diagnostic and prognostic value present controversial and heterogeneous results.

Purpose of the Study:

• To assess the clinical utility of SCCA, SCCA-IgM, and SCCA isoform complexes.
• To highlight the need for standardized detection methods, scoring systems, and cutoff levels for SCCA.
• To emphasize the importance of consistent methodology for dynamic observation of tumor marker kinetics.

Main Methods:

• Review of previous clinical studies on SCCA and its complexes.
• Analysis of the heterogeneity and contrasting results in SCCA's diagnostic and prognostic value.
• Discussion on the requirements for standardized detection and monitoring protocols.

Main Results:

• SCCA has demonstrated potential in diagnosing squamous cancers and monitoring treatment response, relapse, and failure.
• Significant heterogeneity exists across studies, leading to controversy regarding SCCA's definitive clinical value.
• Comparable performances of different detection methods are noted, but standardization is lacking.

Conclusions:

• Standardization of SCCA detection methods, scoring, and cutoff levels is essential to reduce clinical heterogeneity.
• Consistent application of a single method for dynamic observation of tumor marker kinetics is necessary for reliable interpretation.
• Further research with standardized protocols is required to establish the definitive diagnostic and prognostic role of SCCA.